BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25258174)

  • 1. The development of acamprosate as a treatment against alcohol relapse.
    Kufahl PR; Watterson LR; Olive MF
    Expert Opin Drug Discov; 2014 Nov; 9(11):1355-69. PubMed ID: 25258174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acamprosate produces its anti-relapse effects via calcium.
    Spanagel R; Vengeliene V; Jandeleit B; Fischer WN; Grindstaff K; Zhang X; Gallop MA; Krstew EV; Lawrence AJ; Kiefer F
    Neuropsychopharmacology; 2014 Mar; 39(4):783-91. PubMed ID: 24081303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
    Scott LJ; Figgitt DP; Keam SJ; Waugh J
    CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acamprosate for the adjunctive treatment of alcohol dependence.
    Overman GP; Teter CJ; Guthrie SK
    Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical pharmacology of acamprosate.
    Kalk NJ; Lingford-Hughes AR
    Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of acamprosate: an overview.
    Zornoza T; Cano MJ; Polache A; Granero L
    CNS Drug Rev; 2003; 9(4):359-74. PubMed ID: 14647529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acamprosate.
    Kennedy WK; Leloux M; Kutscher EC; Price PL; Morstad AE; Carnahan RM
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):363-80. PubMed ID: 20163323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acamprosate: recent findings and future research directions.
    Mann K; Kiefer F; Spanagel R; Littleton J
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
    Littleton J; Zieglgänsberger W
    Am J Addict; 2003; 12(s1):s3-s11. PubMed ID: 14972776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.
    Kiefer F; Mann K
    Curr Pharm Des; 2010; 16(19):2098-102. PubMed ID: 20482510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acamprosate--a novel treatment for alcoholism].
    Golovko SI; Zefirov SIu; Golovko AI; Shpilenia LS; Nekrasov IuA
    Eksp Klin Farmakol; 2000; 63(3):70-3. PubMed ID: 10934602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate in alcohol dependence: how does it work?
    Littleton J
    Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.
    Liang J; Olsen RW
    Acta Pharmacol Sin; 2014 Aug; 35(8):981-93. PubMed ID: 25066321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior Cingulate Glutamate Is Reduced by Acamprosate Treatment in Patients With Alcohol Dependence.
    Frye MA; Hinton DJ; Karpyak VM; Biernacka JM; Gunderson LJ; Feeder SE; Choi DS; Port JD
    J Clin Psychopharmacol; 2016 Dec; 36(6):669-674. PubMed ID: 27755217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate in the treatment of alcohol dependence.
    Mason BJ
    Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
    Kim SG; Han BD; Park JM; Kim MJ; Stromberg MF
    Psychiatry Clin Neurosci; 2004 Feb; 58(1):30-6. PubMed ID: 14678454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.